SCiAN Approves the Release of EDCpro R7 Platform in Q1 2018


TORONTO, ON – December 11, 2017 – SCiAN is pleased to announce that the Board of Directors has approved the target date of 30-Mar-2018 for the release of EDCpro R7 Platform. R7 represents a major update with enhancements in its core modules:

  • EDCpro for Clinical Databases
  • SAEpro for Safety Databases
  • TMFpro for Trial Master Files.

In addition R7 will introduce 3 new complementary modules:

  • SEDpro: a Site Evaluation Database that helps Sponsors document / track site evaluation and
    performance across multiple studies / programs
  • SCRpro: a Subject Screening Database that allows subjects to be pre-screened into multiple
    programs / studies
  • LTFpro: a Long-term (Safety) Follow-up Database that addresses the needs of clinical
    programs in immuno-oncology, gene therapy and other indications that require multi-year
    follow-up from a large number of studies.

About SCiAN

SCiAN Services is a North American leading Clinical Data Management – Biostatistics – Pharmacovigilance CRO and EDC solution provider. Drug developers (Biotech/Biopharma, and pharmaceutical companies) rely on SCiAN’s 27 years of experience in IND stage clinical trials phases I-III. SCiAN’s therapeutic area expertise developed in over 650 clinical trials includes oncology, CNS, infectious diseases, inflammatory / autoimmune diseases, diabetes, etc. The company’s service depth is further backed by its industry renowned EDCpro platform, custom developed for small to medium size drug development companies and their CROs.

For more information, please contact:

Jasna Szwagiel
Corporate Communication

SCiAN Services, Inc.
Toronto, ON Canada M9P 3V4
Ph: 416 231 8008
Fx: 416 231 1422

SCiAN Services USA, Inc.
King of Prussia, PA 19406
Ph: 610-945-1763
Fx: 610-945-2001

SCiAN Services USA, Inc.
Walnut Creek, CA 94597
Ph: 925-407-2069
Fx: 925-407-4769

Toll-free (U.S. & Canada): 1 800 915 9315